Chypyha Joan 4

What Happened
Joan Chypyha, a director of Edesa Biotech, was granted 19,000 restricted share units (RSUs) on 2026-05-27. The Form 4 reports an acquisition (transaction code A) at $0.00 per share (no cash paid). The award was reported on 2026-05-29.

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-29 (timely filing).
• Transaction type/code: Grant / Award (A).
• Shares/units granted: 19,000 RSUs; per-unit price reported: $0.00 (award).
• Shares owned after transaction: not specified in the provided filing.
• Footnote: The RSUs were issued under the Issuer's 2019 Equity Incentive Compensation Plan and "shall vest in equal proportions over twelve (12) months, commencing on the grant date." (Footnote F1)
• No sale or purchase of shares occurred—this is compensation, not an open-market trade.

Context
RSU grants are a form of equity compensation that typically convert to actual shares only as they vest and may be forfeited if vesting conditions aren’t met. Such awards are common for directors and employees and reflect compensation rather than a direct bullish or bearish trading signal.